SS
TRML

SBI Securities’s Tourmaline Bio TRML Stock Holding History

SBI Securities’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2
Closed -$96 – 4224
2025
Q3 		$96 Sell
2
-1
-33% -$28 ﹤0.01% 3532
2025
Q2 		$48 Hold
3
– – ﹤0.01% 3729
2025
Q1 		$46 Hold
3
– – ﹤0.01% 3676
2024
Q4 		$61 Buy
+3
New +$76 ﹤0.01% 3595

SBI Securities's TRML Position: Q4 2025 in Review

SBI Securities sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 2 shares — an estimated $96 sold.

SBI Securities first reported a position in TRML in Q4 2024 and held it in 4 quarters. The position peaked at $96 in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

  • SBI Securities reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
  • SBI Securities sold 2 Tourmaline Bio shares in Q4 2025, an estimated $96.
  • SBI Securities first reported a position in Tourmaline Bio in Q4 2024 and held it in 4 quarters.
  • SBI Securities's Tourmaline Bio position peaked at $96 in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on SBI Securities's 13F filing for Q4 2025, filed 3 Feb 2026.